CV

Chapter 19

Heart Failure

  • General Definition: Heart failure is a broad term describing various cardiac dysfunctions leading to inadequate tissue perfusion.

  • Patient Presentation: A patient may complain of shortness of breath during activity.

  • Core Problem: The heart's inability to maintain sufficient cardiac output to meet the metabolic demands of tissues and organs.

  • Results:

    • Congestion of blood flow in systemic or pulmonary venous circulation.
    • Inability to increase cardiac output to meet the demands of activity or increased tissue metabolism.
  • Incidence: Increasing, and it's the most common reason for hospitalization in individuals over 65.

  • Etiology and Pathogenesis:

    • HF is a potential consequence of most cardiac disorders.
    • Most common cause is myocardial ischemia, followed by hypertension and dilated cardiomyopathy.
    • Results from impaired ability of myocardial fibers to contract (systolic failure), relax (diastolic failure), or both.
    • Involves issues with the heart's muscle, valves, electrical conduction, and blood supply.
  • Left vs. Right Heart Failure:

    • Left ventricular failure is the most common.
    • Often leads to right ventricular failure.
  • Right Heart Failure: Can result from increased left ventricular filling pressure reflected into the pulmonary circulation (pulmonary hypertension).

  • Symptoms and Signs of Heart Failure:

    • Decreased Forward Flow:
      • Fatigue.
      • Weakness.
      • Shortness of breath.
    • Backup of Flow:
      • Increased JVP (Jugular Venous Pressure).
      • Edema.
      • Ascites.
    • Pulmonary Congestion:
      • Shortness of breath.
      • Orthopnea.
      • Paroxysmal Nocturnal Dyspnea.
    • Increased Right Heart Work.
  • Additional Symptoms:

    • Coughing.
    • Pleural effusion (excess fluid around lungs).
    • Swelling in the abdomen (ascites).
    • Tiredness.
    • Swelling in ankles and legs.
    • Pulmonary edema (excess fluid in lungs).
  • Preload: BP in the left ventricle after filling and before ventricles contract. Originates from the venous system.

  • Afterload: BP in the systemic system that the heart must work against. Created by the arteries.

  • Compensatory Mechanisms and Remodeling: Initially helpful in restoring cardiac output but detrimental long-term.

    • Current management of HF is directed toward reducing the harmful consequences of these compensatory responses.
  1. Sympathetic Nervous System Activation:
    • Result of baroreceptor reflex stimulation detecting a fall in pressure.
    • CNS increases sympathetic nerve activity to the heart, resulting in venoconstriction.
    • Juxtaglomerular cells release renin, activating the RAAS cascade, increasing sodium and water retention.
  2. Increased Preload:
    • Consequence of reduced EF (Ejection Fraction) with an increase in residual ESV (End-Systolic Volume).
    • Decreased CO (Cardiac Output) to the kidney reduces glomerular filtration, leading to fluid conservation.
    • RAAS cascade activation results in elevated blood volume.
  3. Myocardial Hypertrophy and Remodeling:
    • Results from chronic elevation of myocardial wall tension.
    • High systolic pressure in the ventricle needed to overcome high afterload leads to hypertrophy.
    • Neurohormonal factors have a hypertrophic effect on the heart.
    • Angiotensin II is involved in remodeling.
  • Left-Sided Heart Failure:

    • Backward effects: Accumulation of blood within the pulmonary circulation, causing pulmonary congestion and edema.
    • Forward effects: Insufficient CO, diminishing oxygen and nutrient delivery to peripheral tissues and organs.
  • Right-Sided Heart Failure:

    • Pulmonary disorders increase pulmonary vascular resistance, leading to high afterload, right ventricular hypertrophy, and eventually right ventricular failure.
    • Backward effects: Congestion in the systemic venous system.
    • Forward effects: Low output to the left ventricle, leading to low CO.
  • Signs of Right Heart Failure: Elevated JVP, edema (swelling) in the leg, ankle, and foot.

  • Left-Sided HF vs. Right-Sided HF:

    • Left-Sided HF:
      • Backward Effects: Dyspnea on exertion, orthopnea, cough, paroxysmal nocturnal dyspnea, cyanosis, basilar crackles.
      • Forward Effects: Fatigue, oliguria, increased heart rate, faint pulses, restlessness, confusion, anxiety.
    • Right-Sided HF:
      • Backward Effects: Hepatomegaly, ascites, splenomegaly, anorexia, subcutaneous edema, jugular vein distention.
      • Forward Effects: Fatigue, oliguria, increased heart rate, faint pulses, restlessness, confusion, anxiety.
  • Biventricular Heart Failure:

    • Most often the result of primary left-sided HF progressing to right-sided HF.
    • Reduced CO.
    • Pulmonary congestion (due to left-sided HF).
    • Systemic venous congestion (due to right-sided HF).
  • Class and Stage of Heart Failure:

    • FACES: Fatigue, activity limitation, congestion, edema, shortness of breath.
    • Diagnostic assessment includes x-ray and echocardiography.
    • B-type natriuretic peptide level is assessed.
    • Severity of symptoms is used to identify the class/stage of HF.
  • Treatment of Heart Failure:

    • Increase forward flow (cardiac output).
    • Decrease backup of flow (reduce the heart’s workload).
    • Aimed at improving CO while minimizing congestive symptoms and cardiac workload.
    • Obtained by manipulating preload, afterload, and contractility.
  • Treatment Strategies:

    • Increase the force of ventricular contraction using inotropes.
    • Decrease the rate of contraction (using beta blockers) to increase filling time, which subsequently increases the force of ventricular contraction.
      • Enhances cardiac output and forward flow while decreasing backup of flow and the heart's workload.
    • Decrease preload: Dilate veins, reduce intravascular volume using nitrates and diuretics.
    • Decrease afterload: Dilate arteries using ACE inhibitors and hydralazine.
  • Specific Treatments:

    • Preload: Reduces intravascular volume with diuretics and ACE inhibitors.
    • Afterload: β-blockers.
    • Contractility: Digitalis or other cardiac glycosides.
    • Pacemakers may be used to help synchronize ventricular contraction.

Cardiac Dysrhythmias

  • Definition: Disturbance of the heart rhythm.

  • Range: From occasional “missed” or rapid beats to severe disturbances that affect the pumping ability of the heart.

  • Electrical Activity: Uncoordinated.

  • Three Major Types:

    • Abnormal rates of sinus rhythm.
    • Abnormal sites (ectopic) of impulse initiation.
    • Disturbances in conduction pathways.
  • Significance:

    • Indicate an underlying pathophysiologic disorder.
    • May impair normal CO.
  • Treatment:

    • Indicated when dysrhythmias produce significant symptoms or are expected to progress to a more serious level.
    • Antiarrhythmic drugs are used (may be proarrhythmic).
    • Measures to improve CO (pacemakers and drugs to increase contractility).
    • Ablation procedures.